NEVVI Medicare utilization intelligence

← back

ABERGER, MICHAELM.D. NPI 1346533924 Clinician

Urology · SAINT JOSEPH, MO

Specialty Urology — from billed Medicare claims
Trained MEDICAL COLLEGE OF WISCONSIN — medical school, self-reported to CMS
In practice about 15 years since medical school (class of 2011, self-reported to CMS)
Location SAINT JOSEPH, MO · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 67 codes billed · 50,514 disclosed services (CY2024 — most recent year in data)
Current groups
member of 3 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20192026
COMMUNITY HOSPITAL ASSOCIATION
2026
SULLIVAN COUNTY MEMORIAL HOSPITAL
2025–2026
PHOENIX UROLOGY OF ST JOSEPH INC
2019–2026
EXCELSIOR SPRINGS CITY HOSPITAL
2023

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-06

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
87798 Detection test by nucleic acid for organism, amplified probe technique
J0897 Injection, denosumab, 1 mg
84311 Chemical analysis using spectrophotometry (light)
J0585 Injection, onabotulinumtoxina, 1 unit
51798 Ultrasound measurement of bladder capacity after voiding
J1952 Leuprolide injectable, camcevi, 1 mg
82247 Bilirubin level, total
83069 Urine hemoglobin level
82945 Glucose (sugar) level on body fluid
83986 Body fluid ph level
81007 Urinalysis for bacteria
82570 Creatinine level to test for kidney function or muscle injury
84580 Urobilinogen (metabolism substance) level, urine
84156 Total protein level, urine
82010 Ketone bodies analysis, quantitative
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
87491 Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique
87591 Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique
87640 Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
87651 Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique
87653 Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
87661 Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique
87500 Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique
87641 Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique
87481 Detection test for candida species (yeast), amplified probe technique
87563 Detection of mycoplasma genitalium by dna or rna probe
88120 Cell examination of urine, manual
36415 Insertion of needle into vein for collection of blood sample
84153 Psa (prostate specific antigen) measurement, total
87511 Detection test for gardnerella vaginalis (bacteria), amplified probe technique
81003 Automated urinalysis test
88112 Cell examination of specimen, selective cellular enhancement technique
88305 Pathology examination of tissue using a microscope, intermediate complexity
52000 Diagnostic exam of bladder and urethra using an endoscope
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
74176 Ct scan of abdomen and pelvis without contrast
74018 X-ray of abdomen, 1 view
84154 Psa (prostate specific antigen) measurement, free
76775 Limited ultrasound scan behind abdominal cavity
51741 Electronic assessment of bladder emptying
96372 Injection of drug or substance under skin or into muscle
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
52356 Crushing of stone of ureter with insertion of stent using an endoscope
52310 Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope
74178 Ct scan of abdomen and pelvis before and after contrast
52332 Insertion of stent in ureter using an endoscope
76872 Ultrasound scan of pelvic region through rectum
55700 Biopsy of prostate gland
84403 Testosterone (hormone) level, total
52601 Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope
J0698 Injection, cefotaxime sodium, per gm
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes
52235 Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm
52287 Exam with injections of chemical for destruction of bladder using an endoscope
71250 Ct scan of chest without contrast
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
64581 Insertion of sacral nerve neurostimulator electrode
64590 Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
55866 Surgical removal of prostate and surrounding lymph nodes using an endoscope
55874 Injection of biodegradable material next to prostate
55876 Placement of device in prostate for radiation therapy
38571 Removal of lymph nodes of both sides of pelvis using an endoscope
57425 Surgical repair of vaginal defect using an endoscope

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.